Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Releases New Tool for Toxicity Screening of Chemicals in Food

Today, the U.S. Food and Drug Administration (FDA) released its Expanded Decision Tree (EDT) chemical toxicity and risk screening tool that advances the agency’s commitment to transparency and enhancement of the food chemical safety program. The tool provides a consistent, systematic, and science-based approach to support evaluation of the safety of chemicals in food based on their structure and estimated toxicity. The EDT was evaluated through external peer-review, marking a significant milestone in its development. The agency will engage stakeholders and the public for further feedback on the tool.  

Some chemicals have toxic properties that may pose a risk to human health when we are exposed to them at certain levels. The FDA helps to safeguard the food supply by evaluating the safe use of chemicals as food ingredients and food contact substances. To do this, the FDA uses scientific and regulatory tools to assess the safety of chemicals in food while continually updating these methods to incorporate new approaches.  

The EDT is one example of New Approach Methods, which leverage large data sets to achieve faster and less expensive informative new approaches to chemical assessments that can inform risk management decisions and actions. The EDT has gained widespread international support in recent years. This approach to evaluating the safety of chemicals is a modernized version of the original Cramer Decision Tree toolExternal Link Disclaimer and can be used to screen chemicals based on their structural features. The Cramer Decision Tree tool, which is a scientific tool that sorts chemicals into classes of chronic toxic potential using a series of mainly chemical structure-based questions, has been widely used by scientists to provide a quick, preliminary estimate of a new chemical’s predicted toxicity, especially when the testing data about a chemical is limited. The updated, expanded, and greatly refined set of fully chemical structure-based questions in the FDA’s EDT allows classification of chemicals with greater specificity than the Cramer Decision Tree. The EDT will also help inform the nature and extent of additional testing or evaluation that may be needed to help address potential data gaps for chemicals in food.  The EDT is expected to eventually be used in both pre- and post-market evaluation of chemicals in food to help ensure the food supply remains safe. The FDA anticipates that the EDT will provide information that can be incorporated into the agency’s prioritization of chemicals for post-market review.  

In March 2024, the FDA submitted the EDT for external peer-review. This review collected input from external scientific experts in line with the requirements of the Information Quality Act. The FDA updated the EDT based on the review and is now publicly releasing it to the scientific community for technical consideration. Meanwhile, the FDA is developing a software solution for the EDT for general public use and will further refine the EDT over time with access to more information about chemicals in the food supply and based on public input.  

The FDA will release an informational video to explain the EDT and will hold listening sessions to receive input from interested parties. More details will follow.

For More Information  

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.